Head-to-head · WeighScore
GoodRx vs Sesame Care
By GLP-1 ScorecardUpdated
Score comparison
Sesame Care has the higher recorded score — 87.8/100 to 69.6/100.
Sesame Care grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Choose a provider for Wegovy, Zepbound and oral GLP-1 options through Sesame; care and medication are billed separately, and the annual care headline needs comparison with the shorter plan.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | GoodRx | Sesame Care |
|---|---|---|
| WeighScore | 69.6/100 | 87.8/100 |
| Grade | C | B+ |
| Site position | #132 | #2 |
| Semaglutide | Wegovy pill from $149 at 1.5 mg; injection $199 for two qualifying fills then $349. Separate $39/mo care fee if subscribed; dose/offer conditions apply. | Brand Wegovy pill from $149/mo at 1.5/4 mg; $299 at 9/25 mg, plus required care: from $59/mo on annual subscription or $99 every 28 days (confirm billing) |
| Tirzepatide | Zepbound KwikPen advertised from $299; dose-specific and 28-day supply/refill conditions apply. Separate $39/mo care fee if subscribed; confirm pharmacy quote. | Brand Zepbound vials from $299/mo at 2.5 mg; higher doses cost more and KwikPen pages conflict, plus required care (confirm selected product and billing) |
| Coverage | Prescription savings at participating U.S. pharmacies; Care Direct weight-loss prescribing excludes Alabama and Louisiana. Confirm the specific treatment and pharmacy. | U.S. marketplace; provider and treatment availability varies; confirm your state |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Site position #132 · C
Strengths
- Free prescription discounts can be used without purchasing the weight-loss care subscription
- Current Care Direct menu names oral Wegovy, injectable Wegovy/HD, Foundayo tablets and Zepbound KwikPen
- Publishes a separate $39 monthly care fee rather than presenting it as the medication price
- Official terms name possible medical groups and dispensing pharmacies; the guide explains pharmacy selection
What to consider
- Medication is extra; dose offers do not establish continuing cost. Foundayo and Zepbound self-pay card savings end December 31, 2026
- The Zepbound page has an inconsistent 10 mg lowest-dose label; confirm device, strength and selected quote
- Support and terms differ on the initial care-charge trigger; renewals are automatic and cancellation requires at least one day’s notice
- Care Direct weight-loss treatment excludes Alabama and Louisiana, and the guide says no insurance prior-authorization submissions
- Actual dispensing branch, lab costs and refill timing still require confirmation; canceling does not guarantee a refund
Site position #2 · B+
Strengths
- Provider choice with advertised video visits, follow-ups and continuing messaging
- Branded injection and oral options are described, subject to prescribing, dose, insurance and pharmacy availability
- Quest lab costs are included except in nine named states; alternative lab coverage requires confirmation
- The current semaglutide page explicitly distinguishes branded products from compounded semaglutide, which it says is currently unavailable
What to consider
- The $59 care headline requires an annual subscription and excludes medication; provider-specific care rates may be higher
- Ordinary care is called monthly but also billed every 28 days; longer-term savings arithmetic needs confirmation
- Program refund wording differs from newer terms describing multi-month repricing and a 48-hour renewal notice
- Drug prices depend on dose and promotion; official KwikPen and Foundayo displays contain discrepancies
- The selected clinician, medical practice and dispensing pharmacy were not established by this review
Featured provider
Sesame Care
Sesame Care scores 87.8/100 (B+). Choose a provider for Wegovy, Zepbound and oral GLP-1 options through Sesame; care and medication are billed separately, and the annual care headline needs comparison with the shorter plan.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.